SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mika Miura, Shinya Maekawa, Mitsuaki Sato, Nobutoshi Komatsu, Akihisa Tatsumi, Shinichi Takano, Fumitake Amemiya, Yasuhiro Nakayama, Taisuke Inoue, Minoru Sakamoto, Nobuyuki Enomoto, Deep sequencing analysis of variants resistant to the non-structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection, Hepatology Research, 2014, 44, 13
  2. 2
    A. Egli, A. Levin, D. M. Santer, M. Joyce, D. O'Shea, B. S. Thomas, L. F. Lisboa, K. Barakat, R. Bhat, K. P. Fischer, M. Houghton, D. L. Tyrrell, D. Kumar, A. Humar, Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus, Journal of Infectious Diseases, 2014, 210, 5, 717

    CrossRef

  3. 3
    Saba Khaliq, Noreen Latief, Shah Jahan, Role of different regions of the hepatitis C virus genome in the therapeutic response to interferon-based treatment, Archives of Virology, 2014, 159, 1, 1

    CrossRef

  4. 4
    Adrian Egli, Deanna M Santer, Daire O’Shea, D Lorne Tyrrell, Michael Houghton, The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections, Emerging Microbes & Infections, 2014, 3, 7, e51

    CrossRef

  5. 5
    Marina Kawaguchi-Suzuki, Reginald F. Frye, The Role of Pharmacogenetics in the Treatment of Chronic Hepatitis C Infection, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2014, 34, 2
  6. 6
    Ming-Yao Chen, Chen-Hua Liu, Ting-Chih Chen, Tung-Hung Su, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao, Chun-Jen Liu, Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin, Journal of Gastroenterology and Hepatology, 2014, 29, 1
  7. 7
    Norio Akuta, Fumitaka Suzuki, Yuya Seko, Yusuke Kawamura, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Tasuku Hara, Mariko Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada, Emergence of telaprevir-resistant variants detected by ultra-deep sequencing after triple therapy in patients infected with HCV genotype 1, Journal of Medical Virology, 2013, 85, 6
  8. 8
    Chen-Hua Liu, Jia-Horng Kao, IL28B Genotype on HCV Infection in Asia, Current Hepatitis Reports, 2013, 12, 3, 149

    CrossRef

  9. 9
    Antonio Rivero-Juarez, Luis F. Lopez-Cortes, Angela Camacho, Antonio Caruz, Almudena Torres-Cornejo, Loreto Martinez-Dueñas, Rosa Ruiz-Valderas, Julian Torre-Cisneros, Alicia Gutierrez-Valencia, Antonio Rivero, The IL28B effect on hepatitis C virus kinetics among HIV patients after the first weeks of pegylated-interferon/ribavirin treatment varies according to hepatitis C virus-1 subtype, AIDS, 2013, 27, 12, 1941

    CrossRef